Navigation Links
New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery
Date:3/26/2009

NEW YORK, NY (March 25, 2009) Transdermal delivery of estrogen therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral delivery, a new study suggests. The study was conducted by researchers at NYU Langone Medical Center and was published in the latest issue of Menopause: The Journal of the North American Menopause Society.

Prescription transdermal estrogen therapy is bioidentical to estrogen produced by a woman's ovaries before menopause and delivered through the skin. Transdermal estrogen is available in a variety of formulations which have been quality controlled and approved safe and effective by the United States Food and Drug Administration (FDA).

The team at NYU Langone sought to determine the effects of delivery of estrogen therapy on postmenopausal women. Blood obtained from 84 postmenopausal women was tested for clotting activity before and after administration of oral or transdermal estrogen for a period of eight weeks. Women with borderline clotting issues showed "a significant acceleration" of clotting after oral estrogen therapy, but no significant change after transdermal estrogen therapy.

"Venous thromboembolic complications or blood clots represent an established risk factor of estrogen therapy, and evidence is now mounting that the route of estrogen administration influences this risk," said researcher Lila Nachtigall, M.D., Director of the Women's Wellness Program at NYU. "These new data on the safety of transdermal HT delivery may prove to be useful information for postmenopausal women deciding whether to take estrogen therapy and whether to take it orally or through the skin."

The research team studied platelet activity in the study participants' blood. Platelets serve a central role in forming pathological arterial thrombosis that causes myocardial infarction and stroke. The study's au
'/>"/>

Contact: Lorinda Klein
lorindaann.klein@nyumc.org
212-404-3533
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Autism Study Finds Significant Benefit with Hyperbaric Treatment
2. Danon Disease Can Be Quickly Fatal, Study Finds
3. NYU study finds new risk factor for melanoma in younger women
4. Study helps identify college drinkers who might continue excessive drinking as adults
5. Study finds program has improved health agencies preparedness for bioterror and disease outbreaks
6. GAO Study Links Duty Circumvention with Evasion of Food Safety Laws
7. Study IDs Variations in Black, White Genomes
8. Researchers studying hearing loss find auditory regions of the brain convert to the sense of touch
9. Pilot Study Using Video Cell Phones for Mobile Direct Observation Treatment (MDOT) to Monitor Medication Compliance of TB Patients
10. Study shows how Salmonella survives in environment
11. Study IDs Gene Variants Tied to Sudden Cardiac Death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...irstCall/ -- Care Investment Trust Inc. (NYSE: ...hat its Board of Directors has declared a dividend... is payable on December 22, 2009 to common shareho...out Care Investment Trust ,, Care Investment T...company investing in healthcare-related real estat...
(Date:12/4/2009)...swire/ -- Medithrive, Inc. has won the Patient,s C...ay Area by popular vote conducted by the online we...hs in operation, the SF Bay community has selected...ng medicinal marijuana. ,, The rapid rise and...dispensary which caters to the consumer, provides ...
(Date:12/4/2009)...-USNewswire/ -- The American Association of Homes ...nate for ensuring that the Community Living and S...e final health reform legislation . The CLASS prov...rs, people with disabilities and their caregivers....eform bill that will make it affordable to care fo...
(Date:12/4/2009)...Newswire/ -- The large, two-day free health clinic...nics (NAFC) in Kansas City on Wednesday and Thursd...o is uninsured and has not seen a doctor recently....e preventive primary care. ,, "Many people who...nts this fall in Houston, New Orleans and Little R...
(Date:12/4/2009)...Newswire/ -- Pamela Bowen, Chief Information Offic...ist for the "Chief Innovation Officer" Appy Award ...r of cloud computing. Appy Award recipients are no...rce CRM or the Force.com platform in bringing new ...ng, partner, service, support or IT organizations....
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
..., The Association for Gerontology in Higher Educ...ntological Society of America , will hold its 35t...ence February 26March 1, 2009, at the Crowne Pla... about gerontological and geriatric education and ...
..., CARLSBAD, Calif., Jan. 30 Beautiful skin wi...you may actually save money on skin care,this year...tress level and,cleaning out your cabinets. , ...skin. With the ten thrifty tips, this host of "Ski...
..., RED BANK, New Jersey, BRUSSELS and MELBOURNE...obal corporate,website. With over a century of exp...otective solutions is now rethinking its presence ... The site includes corporate information with ...
..., Three New Studies Initiated in Other Oncology Se...0 GlaxoSmithKline (GSK) and Genmab A/S (OMX: GEN)...ense Application (BLA) to the U.S. Food and Drug A...erapies. If approved, ofatumumab would be the firs...
..., SAN DIEGO and LISLE, Ill., Jan. 30 SpineMar...that partners with hospitals and,physicians to dev... a,partnership with Healthplace America to deliver...Surgery Benefit(TM). As a result,of their affilia...
..., MIAMI, Jan. 30 Physicians Healthcare Managemen...developer of health maintenance organizations (HMO...hyshield Insurance Exchange, a licensed medical ma...ongress and a new administration in Washington. H...
Other Medicine News:Health News:Teaching about financial crisis among Gerontology Meeting's highlights 2Health News:Ten Thrifty Tips for Radiant Skin 2Health News:Ten Thrifty Tips for Radiant Skin 3Health News:Ansell Limited Launching a New Global Website 2Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 2Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 3Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 4Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 5Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 6Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 7Health News:GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer 8Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 2Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 3Health News:SpineMark Partners With Healthplace America to Offer Access to Top Quality Spinal Care 4Health News:Phyhealth Provides Update to Shareholders 2Health News:Phyhealth Provides Update to Shareholders 3Health News:Phyhealth Provides Update to Shareholders 4
(Date:12/4/2009)..., , INDIANAPOLIS, Dec. 4 /PRNewswire-...ion (FDA) today approved Zyprexa® (olanzapine... schizophrenia and manic or mixed episodes associa...-17 years old. ,, The updated Zyprexa label st...n the increased potential for weight gain and hype...
(Date:12/4/2009)..., , OMAHA, Neb., Dec. 4 Am...editation by the Accreditation Commission for Heal...ices. For nearly 15 years, Amber Pharmacy has prov...ices to meet the unique needs of specialized condi...ers of services to transplant programs. They work ...
(Date:12/4/2009)..., , STREAMWOOD, Ill., Dec. 4 /PRNewswire/...f CT, MRI and PET/CT systems and service programs ... to announce it has received The Joint Commission,...onally-recognized, prestigious gold seal of approv...Imaging accreditation is system-wide for its mobil...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Amber Pharmacy Earns Accreditation From ACHC 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Gut worms may protect against house dust mite allergy 58400 1Gut worms may protect against house dust mite allergy 58400 2Gut worms may protect against house dust mite allergy 58400 3Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 1Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 2Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 3Canker disease in eucalyptus in the Basque Country 10128 1Canker disease in eucalyptus in the Basque Country 10128 2Canker disease in eucalyptus in the Basque Country 10128 3Canker disease in eucalyptus in the Basque Country 10128 4
... ANTIPOLIS, France, Nov. 7 NicOx S.A.,(Eurolist: ...xploratory,pharmacodynamic study for naproxcinod u...ere presented yesterday at the American Heart,Asso...ida. Naproxcinod is,the first compound in the COX-...ammatory agents and is in clinical development for...
..., Nov. 7 Vital Therapies, Inc. (VTI), announced,t...) (Extracorporeal Liver,Assist Device) System were...e Study of Liver Diseases (AASLD) Annual Meeting, ...Abstract (#91), "Interim results of Randomized Con...Liver Disease," was presented in a parallel s...
Other Medicine Technology:NicOx' Naproxcinod ABPM Data Presented at American Heart Association 2NicOx' Naproxcinod ABPM Data Presented at American Heart Association 3NicOx' Naproxcinod ABPM Data Presented at American Heart Association 4Vital Therapies Announces Presentation of ELAD(R) 'Artificial Liver' Data at American Association for the Study of Liver Diseases 2007 Annual Meeting 2
AGC Revision knee
Advance Stemmed Medial-Pivot Knee
AGC Dual Articular Knee
Scorpio TS Single Axis Revision Knee System
Medicine Products: